vaccines

Medical societies endorse ACOG’s schedule, saying maternal vaccines are ‘key element’ of protection The leading professional organization for obstetricians and gynecologists in the US has launched its first maternal vaccination schedule and diverged for the first time from federal recommendations. The American College of Obstetricians and Gynecologists (ACOG) has long recommended giving the shots…

Researchers at the Keck School of Medicine of USC, the Brain and Creativity Institute at the USC Dornsife College of Letters, Arts and Sciences, and the USC Norris Comprehensive Cancer Center have launched the University of Southern California's first study of psychedelic therapy.

Neisseria gonorrhoeae is a strictly human-adapted Gram-negative bacterium and the causative agent of gonorrhoea, a sexually transmitted infection of major global health importance. Disease control is increasingly compromised by the rapid emergence of resistance to multiple antimicrobial classes and by the failure of natural infection to induce durable protective immunity. The ability of N. gonorr…

In a milestone clinical trial published in the Journal of Clinical Investigation, researchers with the UNC Institute for Global Health and Infectious Diseases (IGHID) at the UNC School of Medicine have demonstrated that new vaccines can significantly boost T cells targeting the most vulnerable, conserved regions of HIV--areas considered key to effective immune control.

(Ars Technica) – Thirteen other medical groups have already endorsed the independent schedule. ACOG’s 2026 Maternal Immunization Schedule differs most significantly from the CDC’s current schedule by including recommendations for COVID-19 and seasonal influenza vaccines. Those vaccines have been dropped from the … Read More

Health advocates criticized Kennedy’s move demanding answers from journal that removed ‘flawed’ vaccine study Robert F Kennedy Jr, the US health secretary, is demanding answers from a medical journal that recently removed a paper suggesting a link between vaccines and infant death, saying their decision was “of great interest to me”. Public health advocates immediately criticized the move, and sa…

A target trial emulation of older adults entering skilled-nursing facilities found that those who received the recombinant shingles vaccine (RZV) had a lower risk of developing dementia over the following four years compared with those who were not vaccinated.

Vitamin K lowers the risk of bleeding, including in a circumcision. That procedure may explain a disparity in which infants are more likely to get the shot.

A new study led by researchers at Washington University School of Medicine in St. Louis has found that an investigational mRNA influenza vaccine helps the immune system recognize a wider range of influenza viruses than today's standard flu shot, offering stronger and potentially longer-lasting protection.

A new nanodisc breakthrough lets scientists see viruses more realistically, revealing hidden clues that could lead to better vaccines. Viruses are highly effective at infecting human cells, largely because of specialized proteins that cover their outer surfaces. These proteins are also a key focus for vaccine design. To study them, scientists often create lab-made versions [...]

WashU Medicine researchers Ali Ellebedy, PhD, and Hanover Matz, PhD, have found that Moderna's mRNA flu vaccine that is currently under review by the FDA triggers an immune response against a wide array of flu strains, potentially offering stronger and longer-lasting protection.

Nature Immunology, Published online: 15 June 2026; doi:10.1038/s41590-026-02569-5 This study compares the humoral response of individuals who received inactivated influenza vaccines to that of individuals who received an mRNA-based quadrivalent influenza vaccine. The mRNA-based vaccine induced prolonged germinal center responses, more antibodies and increased numbers of memory B cells.

Developing a universally effective vaccine has proven difficult thanks to the complex immune mechanisms involved. In DENV cases, the initial immunity after first infection paradoxically increases the risk of severe disease, rather than conferring protection, when a person is infected a second time with a different serotype of the virus

We have a VACCINE against CANCER. For 20 years now! The first Human Papillomavirus (HPV) vaccine, Gardasil, was approved in June, 2006. Since then, the rate of cervical cancer has dropped by 62 percent in the United States. HPV also causes vulvar, vaginal, anal, and penile, tongue, and throat cancers, and the vaccine protects against […] The post The HPV Vaccine Is 20 Years Old. Let’s Celebrate! …

Thalassemia management relies on blood donations and prevention strategies, crucial for reducing the disease's impact on families and healthcare systems.

IntroductionNatural products, especially polyphenol-rich medicinal plants, are increasingly investigated as multitarget therapeutics in both human and veterinary medicine for angiogenic regenerative properties and for inflammation based-diseases. Recent developments in natural product formulation, notably microencapsulation, have been shown to improve stability, bioavailability, and controlled re…

As Ebola rages, Moderna and others are racing to develop an mRNA vaccine for the rare Bundibugyo virus driving the current outbreak

Brazilian authorities have stressed that the 42 cases of severe adverse events out of half-a-million vaccinated represent only 0.008%. There is no doubt that it is a small risk at the population level. At the individual level, however, even one life lost to a severe adverse event is one too many

For many people, the flu is an unpleasant but temporary illness. A few days of fever, cough, sore throat, body aches, and fatigue are followed by recovery and a return to normal life. However, for older adults, influenza can be much more dangerous. What starts as a simple infection can quickly develop into serious complications […] The post A Stronger Flu Vaccine Could Offer Better Protection for…